BIOXXMED AG

Explore how BIOXXMED AG drives biotech innovation, tackling chronic wounds, vascular disease, and cancer with pioneering small‑molecule and biologic therapies.

BioXXmed AG, a German biotechnology company, is navigating the challenges of drug development and market volatility as it works to deliver innovative treatments for chronic wounds, vascular diseases, and cancer.